APA (7th ed.) Citation

V, L., & M, B. (2026). When clinical trials fail to represent patients: Implications for schizophrenia guidelines. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 110, 112856. https://doi.org/10.1016/j.euroneuro.2026.112856

Chicago Style (17th ed.) Citation

V, Llorca-Bofí, and Bioque M. "When Clinical Trials Fail to Represent Patients: Implications for Schizophrenia Guidelines." European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 110 (2026): 112856. https://doi.org/10.1016/j.euroneuro.2026.112856.

MLA (9th ed.) Citation

V, Llorca-Bofí, and Bioque M. "When Clinical Trials Fail to Represent Patients: Implications for Schizophrenia Guidelines." European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 110, 2026, p. 112856, https://doi.org/10.1016/j.euroneuro.2026.112856.